251 related articles for article (PubMed ID: 32500289)
1. Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes.
Rodrigues KB; Dufort MJ; Llibre A; Speake C; Rahman MJ; Bondet V; Quiel J; Linsley PS; Greenbaum CJ; Duffy D; Tarbell KV
Diabetologia; 2020 Aug; 63(8):1576-1587. PubMed ID: 32500289
[TBL] [Abstract][Full Text] [Related]
2. A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes.
Guo M; Guo H; Zhu J; Wang F; Chen J; Wan C; Deng Y; Wang F; Xu L; Chen Y; Li R; Liu S; Zhang L; Wang Y; Zhou J; Li S
Diabetologia; 2024 Apr; 67(4):623-640. PubMed ID: 38349399
[TBL] [Abstract][Full Text] [Related]
3. Despite Increased Type 1 IFN, Autoimmune Nonobese Diabetic Mice Display Impaired Dendritic Cell Response to CpG and Decreased Nuclear Localization of IFN-Activated STAT1.
Rahman MJ; Rahir G; Dong MB; Zhao Y; Rodrigues KB; Hotta-Iwamura C; Chen Y; Guerrero A; Tarbell KV
J Immunol; 2016 Mar; 196(5):2031-40. PubMed ID: 26826238
[TBL] [Abstract][Full Text] [Related]
4. Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice.
Rahman MJ; Rodrigues KB; Quiel JA; Liu Y; Bhargava V; Zhao Y; Hotta-Iwamura C; Shih HY; Lau-Kilby AW; Malloy AM; Thoner TW; Tarbell KV
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415894
[TBL] [Abstract][Full Text] [Related]
5. Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes.
Cabrera SM; Engle S; Kaldunski M; Jia S; Geoffrey R; Simpson P; Szabo A; Speake C; Greenbaum CJ; ; Chen YG; Hessner MJ
Diabetologia; 2018 Nov; 61(11):2356-2370. PubMed ID: 30167736
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
Wreven E; Ruiz de Adana MS; Hardivillé S; Gmyr V; Kerr-Conte J; Chetboun M; Pasquetti G; Delalleau N; Thévenet J; Coddeville A; Vallejo Herrera MJ; Hinden L; Benavides Espínola IC; Gómez Duro M; Sanchez Salido L; Linares F; Bermúdez-Silva FJ; Tam J; Bonner C; Egan JM; Olveira G; Colomo N; Pattou F; González-Mariscal I
Diabetologia; 2024 Jun; ():. PubMed ID: 38864887
[TBL] [Abstract][Full Text] [Related]
7. Heightened interferon-alpha/beta response causes myeloid cell dysfunction and promotes T1D pathogenesis in NOD mice.
Peng RH; Paek E; Xia CQ; Tennyson N; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():99-102. PubMed ID: 17130537
[TBL] [Abstract][Full Text] [Related]
8. Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic background.
Koarada S; Wu Y; Olshansky G; Ridgway WM
J Immunol; 2002 Dec; 169(11):6580-7. PubMed ID: 12444170
[TBL] [Abstract][Full Text] [Related]
9. Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas.
Rothe H; Ito Y; Kolb H
J Mol Med (Berl); 2001 May; 79(4):190-7. PubMed ID: 11409710
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
[TBL] [Abstract][Full Text] [Related]
12. IFNɣ but not IFNα increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity.
Thomaidou S; Munoz Garcia A; de Lange S; Gan J; van der Slik AR; Hoeben RC; Roep BO; Carlotti F; Zaldumbide A
Diabetologia; 2023 Nov; 66(11):2075-2086. PubMed ID: 37581620
[TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D
Ysmail-Dahlouk L; Nouari W; Aribi M
Immunol Lett; 2016 Nov; 179():122-130. PubMed ID: 27717877
[TBL] [Abstract][Full Text] [Related]
14. Investigation of coordination and order in transcription regulation of innate and adaptive immunity genes in type 1 diabetes.
Gao S; Wolanyk N; Chen Y; Jia S; Hessner MJ; Wang X
BMC Med Genomics; 2017 Jan; 10(1):7. PubMed ID: 28143555
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variations in transferred progeny due to genotype of surrogate mother.
Gerlinskaya LA; Litvinova EA; Kontsevaya GV; Feofanova NA; Achasova KM; Anisimova MV; Maslennikova SO; Zolotykh MA; Moshkin YM; Moshkin MP
Mol Hum Reprod; 2019 Feb; 25(2):88-99. PubMed ID: 30445548
[TBL] [Abstract][Full Text] [Related]
16. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.
Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA
mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459
[TBL] [Abstract][Full Text] [Related]
17. Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetes.
Janssen AWM; Stienstra R; Jaeger M; van Gool AJ; Joosten LAB; Netea MG; Riksen NP; Tack CJ
Metabolism; 2021 Aug; 121():154795. PubMed ID: 33971203
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
19. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
20. Knockout of vascular smooth muscle EGF receptor in a mouse model prevents obesity-induced vascular dysfunction and renal damage in vivo.
Stern C; Schreier B; Nolze A; Rabe S; Mildenberger S; Gekle M
Diabetologia; 2020 Oct; 63(10):2218-2234. PubMed ID: 32548701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
